Summaries of Product Characteristics (SPC) for Human medicinal products

The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.

Summaries of Product Characteristics 241 - 270 of 324
<  Previous 30    |  1  2  3  4  5  6  7  8  9  10  11  |  Next 30   >
Package leaflet	Status for supply	Name of the medicinal product
PL	Resepti	Montelukast Krka 4 mg purutabletti SPC 2023-12-14
PL	Resepti	Montelukast Krka 5 mg purutabletti SPC 2023-12-14
PL	Resepti	Montelukast Mylan 5mg purutabletti SPC 2021-02-12
PL	Resepti	Montelukast Organon 10 mg tabletti, kalvopäällysteinen SPC 2023-04-21
PL	Resepti	Montelukast Organon 4 mg purutabletti SPC 2023-04-21
PL	Resepti	Montelukast Organon 4 mg rakeet SPC 2023-04-21
PL	Resepti	Montelukast Organon 5 mg purutabletti SPC 2023-04-21
PL	Resepti	Montelukast Orion 10 mg tabletti SPC 2024-01-02
PL	Resepti	Montelukast Orion 5 mg purutabletti SPC 2024-01-02
PL	Resepti	Montelukast ratiopharm 10mg tabletti, kalvopäällysteinen SPC 2023-10-17
PL	Resepti	Montelukast ratiopharm 4 mg purutabletti SPC 2023-11-22
PL	Resepti	Montelukast ratiopharm 5 mg purutabletti SPC 2023-11-22
PL	Resepti	Montelukast Sandoz 10 mg tabletti, kalvopäällysteinen SPC 2024-01-09
PL	Resepti	Montelukast Stada 4 mg, 5 mg purutabletit, 10 mg kalvopäällysteiset tabletit SPC 2010-10-25
PL	Resepti	Montelukast Symphar 4 mg, 5 mg purutabletti, 10 mg tabletti SPC 2010-02-23 .doc
PL	Resepti	Monuril 3 g rakeet oraaliliuosta varten, annospussi SPC 2024-03-04
PL	Resepti	Morphin 2 mg-ml injektioneste, liuos SPC 2024-10-28
PL	Resepti	Morphin 20 mg-ml injektioneste, liuos SPC 2024-10-28
PL	Resepti	Motifene Dual 75 mg depotkapseli SPC 2022-10-03
		European Medicines Agency's website: Mounjaro - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Moventig - EMA: EPAR PI Finnish Swedish
PL	Itsehoito	Movicol Appelsiini konsentraatti oraaliliuosta varten SPC 2023-05-02
PL	Itsehoito	Movicol Chocolate jauhe oraaliliuosta varten, annospussi SPC 2023-04-06
PL	Itsehoito	Movicol jauhe oraaliliuosta varten, annospussi SPC 2023-04-06
PL	Resepti	Movicol Junior Chocolate jauhe oraaliliuosta varten, annospussi SPC 2023-04-06
PL	Resepti/itsehoito	Movicol Junior Plain jauhe oraaliluosta varten, annospussi SPC 2023-04-06
PL	Itsehoito	Movicol Plain jauhe oraaliliuosta varten, annospussi SPC 2023-04-06
PL	Itsehoito	Movicol Ready to Take oraaliliuos, annospussi SPC 2023-03-24
PL	Itsehoito	Moviprep Appelsiini jauhe oraaliliuosta varten SPC 2024-05-15
PL	Itsehoito	Moviprep jauhe oraaliliuosta varten SPC 2024-05-15
<  Previous 30    |  1  2  3  4  5  6  7  8  9  10  11  |  Next 30   >